JPRN-UMIN000025050招募中未知
Efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C - EBR/GZR
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology0 个研究点目标入组 500 人开始时间: 2016年11月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Contraindication to elbasvir or grazoprevir 2) Contraindication to elbasvir and grazoprevir
研究者
相似试验
已完成
不适用
Safety and efficacy of Grazoprevir and Elbasvir combination therapy for hemodialyzed patients with genotype 1 chronic hepatitis C infectiohemodialyzed patients with chronic hepatitis C infectionJPRN-UMIN000025784Graduate School of Medicine, Hokkaido University60
已完成
不适用
Prospective study of Grazoprevir and Elbasvir for HCV genotype 1 intected Japanese patientsHCV genotype 1 infected chronic liver diseaseJPRN-UMIN000025191Osaka City University and affiliated hospital119
招募中
不适用
Evaluation of the efficacy of elbasvir and glazopurevir for Japanese hepatitis C patients: a prospective study in real life settings.JPRN-UMIN000026908Toranomon Hospital100
已完成
4 期
Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infectionChronic Hepatitis CNCT03098121Taoyuan General Hospital40
已完成
不适用
Efficacy and safety of glecaprevir and pibrentasvir in chronic hepatitis C patients with hemodialysisChronic hepatitis C with hemodialysisJPRN-UMIN000029781kitasato University school of medicine50